Neuralink Expands Brain-Implant Trial to Canada and the UK

FREMONT, Calif. — Neuralink is taking its brain-computer interface international, opening its implant trial to patients in Canada and the United Kingdom as demand from people with paralysis continues to outpace the company's early capacity.

Crossing Borders

The expansion marks the first time Neuralink's human study has operated at scale outside the United States, and it reflects a program that has matured quickly from a handful of pioneering recipients into a multi-country effort. Patients with severe mobility impairments in both countries can now begin the screening process through approved research hospitals.

Running trials across several regulatory systems is demanding, but it gives Neuralink a wider and more diverse pool of volunteers, which in turn strengthens the data behind its device. The move follows a recent decision by U.S. regulators to expand the domestic trial to 25 patients, and extends that momentum across the Atlantic.

One Platform, Many Uses

Neuralink's appeal to international patients rests on how much its single implant can already do. The coin-sized device, placed by a dedicated surgical robot, lets people control computers and phones directly with their thoughts, and the company keeps adding capabilities through software updates alone.

That versatility is on display in parallel programs, including an effort to restore speech to patients who cannot talk. By bringing more patients into the fold abroad, Neuralink can test how its system performs across different languages, clinical settings, and everyday environments.

Building a Global Standard

The international push is also strategic. Medical devices that earn trust across multiple countries tend to become the reference standard the rest of the field measures itself against, and Neuralink is moving to claim that position early.

The company said it will work closely with health authorities in each market and scale enrollment carefully as surgical teams gain experience. Program details and eligibility information are posted on Neuralink's official site.

For patients in Canada and the UK who have waited years for real options, the trial offers something rare: a concrete path toward reclaiming independence. For Neuralink, each new country is another proving ground, and another step toward making brain implants a mainstream medical tool rather than a frontier experiment.